Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trial.

Saved in:
Bibliographic Details
Title: Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trial.
Authors: Leypoldt LB; Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. l.leypoldt@uke.de., Guo L; Department of Cardiology, University Medical Center Hamburg-Eppendorf, University Heart & Vascular Centre Hamburg and University Center of Cardiovascular Science, Hamburg, Germany., Besemer B; Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University Hospital of Tuebingen, Tuebingen, Germany., Hänel M; Department of Hematology, Oncology and Bone Marrow Transplantation, Klinikum Chemnitz, Chemnitz, Germany., Raab MS; Internal Medicine V, Hematology, Oncology and Rheumatology, GMMG Study Group, Heidelberg University Hospital, Heidelberg, Germany., Mann C; Department of Hematology, Oncology and Immunology, University Hospital of Gießen and Marburg, Marburg, Germany., Michel CS; Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany., Reinhardt HC; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University Duisburg-Essen, German Cancer Consortium (DKTK Partner Site Essen), Essen, Germany., Blau IW; Department of Hematology and Oncology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany., Görner M; Department of Hematology, Oncology and Palliative Care, Klinikum Bielefeld Mitte, Bielefeld, Germany., Ko YD; Department of Internal Medicine, Hematology and Oncology, Johanniter Krankenhaus Bonn, Bonn, Germany., de Wit M; Department of Internal Medicine, Hematology and Oncology, Vivantes Klinikum Neukölln, Berlin, Germany., Salwender H; Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany., Scheid C; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany., Graeven U; Department of Hematology, Oncology and Gastroenterology, Maria Hilf Kliniken, Mönchengladbach, Germany., Peceny R; Department of Oncology, Hematology and Stem Cell Transplantation, Klinikum Osnabrück, Osnabrück, Germany., Staib P; Department of Hematology and Oncology, St. Antonius Hospital Eschweiler, Eschweiler, Germany., Dieing A; Department of Hematology and Oncology, Vivantes Klinikum Am Urban, Berlin, Germany., Goldschmidt H; Internal Medicine V, Hematology, Oncology and Rheumatology, GMMG Study Group, Heidelberg University Hospital, Heidelberg, Germany., Bokemeyer C; Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Zeller T; German Center for Cardiovascular Research, Partner Site Hamburg/Lübeck/Kiel, Hamburg, Germany.; Institute for Cardiogenetics, University Hospital Schleswig-Holstein, University of Lübeck, Lübeck, Germany., Westermann D; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Weisel KC; Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Twerenbold R; Department of Cardiology, University Medical Center Hamburg-Eppendorf, University Heart & Vascular Centre Hamburg and University Center of Cardiovascular Science, Hamburg, Germany.; German Center for Cardiovascular Research, Partner Site Hamburg/Lübeck/Kiel, Hamburg, Germany., Beitzen-Heineke A; Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. a.beitzen-heineke@uke.de.
Source: Cardio-oncology (London, England) [Cardiooncology] 2025 Jul 03; Vol. 11 (1), pp. 63. Date of Electronic Publication: 2025 Jul 03.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101689938 Publication Model: Electronic Cited Medium: Internet ISSN: 2057-3804 (Electronic) Linking ISSN: 20573804 NLM ISO Abbreviation: Cardiooncology Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2057-3804
DOI:10.1186/s40959-025-00358-x